Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Anti-adrenergic and muscarinic receptor autoantibodies in a canine model of Chagas disease and their modulation by benznidazole.

Daliry A, Caldas IS, de Figueiredo Diniz L, Torres RM, Talvani A, Bahia MT, de Carvalho AC.

Int J Cardiol. 2014 Jan 1;170(3):e66-7. doi: 10.1016/j.ijcard.2013.11.022. No abstract available.

2.

Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease.

Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM.

Microbes Infect. 2006 Aug;8(9-10):2459-64.

PMID:
16963301
3.

The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

Nussinovitch U, Shoenfeld Y.

Clin Rev Allergy Immunol. 2012 Jun;42(3):298-308. doi: 10.1007/s12016-010-8235-x. Review.

PMID:
21207192
4.

Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.

Cutrullis RA, Moscatelli GF, Moroni S, Volta BJ, Cardoni RL, Altcheh JM, Corral RS, Freilij HL, Petray PB.

PLoS One. 2011;6(10):e27133. doi: 10.1371/journal.pone.0027133.

5.

Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy.

Wallukat G, Nissen E, Morwinski R, Müller J.

Herz. 2000 May;25(3):261-6. Review.

PMID:
10904849
6.
7.

[Prevalence of autoantibodies against autonomic receptors in patients with chronic cardiopathies].

Calzada JE, Garisto J, Zebede S, Samudio FE, Blandón R, Avilés O, Saldaña A.

Biomedica. 2009 Mar;29(1):133-9. Spanish. Erratum in: Biomedica. 2013 Jan-Mar;33(1):155. Zebedes, Salomón [corrected to Zebede, Salomón].

8.

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.

Garcia S, Ramos CO, Senra JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB.

Antimicrob Agents Chemother. 2005 Apr;49(4):1521-8.

9.

Agonistic effects of anti-peptide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization.

Wallukat G, Fu ML, Magnusson Y, Hjalmarson A, Hoebeke J, Wollenberger A.

Blood Press Suppl. 1996;3:31-6.

PMID:
8973766
10.

Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.

Levin MJ, Hoebeke J.

Autoimmunity. 2008 Sep;41(6):429-33. doi: 10.1080/08916930802031702. Review.

PMID:
18781468
11.

Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.

Bustamante JM, Presti MS, Rivarola HW, Fernández AR, Enders JE, Fretes RE, Paglini-Oliva P.

Int J Antimicrob Agents. 2007 Jun;29(6):733-7.

PMID:
17395432
12.

Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy.

Borda ES, Sterin-Borda L.

Int J Cardiol. 1996 May;54(2):149-56. Review.

PMID:
8803679
13.

Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoceptor-related autoantibodies.

Sterin-Borda L, Gorelik G, Postan M, Gonzalez Cappa S, Borda E.

Cardiovasc Res. 1999 Jan;41(1):116-25.

14.

Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection.

Rocha NN, Garcia S, Giménez LE, Hernández CC, Senra JF, Lima RS, Cyrino F, Bouskela E, Soares MB, Ribeiro dos Santos R, Campos de Carvalho AC.

Parasitology. 2006 Dec;133(Pt 6):729-37.

PMID:
16978452
15.

The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.

Nussinovitch U, Shoenfeld Y.

Clin Rev Allergy Immunol. 2013 Feb;44(1):75-83. doi: 10.1007/s12016-010-8228-9. Review.

PMID:
21188649
16.

[Presence of antibodies to cardiac neuroreceptors in patients with Chagas disease].

Tovar NC, Echeverry MC, Mora G.

Biomedica. 2009 Sep;29(3):476-94. Spanish.

17.

Autoantibodies against M2-muscarinic and β adrenergic receptors: New mediators in atrial fibrillation?

He B, Lu Z, He W, Jiang H.

Int J Cardiol. 2015 Oct 15;197:180-1. doi: 10.1016/j.ijcard.2015.06.066. No abstract available.

PMID:
26142203
18.

Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction.

Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, Levin MJ.

Circulation. 2001 Apr 3;103(13):1765-71.

19.

Modulation of autoimmunity by treatment of an infectious disease.

Hyland KV, Leon JS, Daniels MD, Giafis N, Woods LM, Bahk TJ, Wang K, Engman DM.

Infect Immun. 2007 Jul;75(7):3641-50.

20.

Autoantibodies in Chagas' cardiomyopathy and arrhythmias.

Chiale PA, Ferrari I.

Autoimmunity. 2001;34(3):205-10. Review. No abstract available.

PMID:
11908779
Items per page

Supplemental Content

Support Center